학술논문
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
Document Type
Article
Author
Source
In Annals of Oncology September 2011 22(9):2137-2143
Subject
Language
ISSN
0923-7534